why choose us

First received: May 17, 2023

Clinical Trial: AMP SCZ® Observational Study: PREDICT-DPACC

Study Status: Completed

Recruit Status: RECRUITING

Condition: Clinical High Risk

Study Type: OBSERVATIONAL


Official Title: Accelerating Medicines Partnership® Schizophrenia Observational Study: Psychosis Risk Evaluation, Data Integration, and Computational Technologies -Data Processing, Analysis, and Coordination Center a

Brief Summary: The Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) is a large international collaboration to develop algorithms using a set of clinical and cognitive assessments, multi-modal biomarkers, and clinical endpoints that can be used to predict the trajectories and outcomes of individuals at clinical high risk (CHR) for psychosis and to advance the testing of pharmacological interventions for CHR individuals in need.The goal is to accurately predict which individuals are likely to remit, experience an acute…

Read more